Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Vandsemb EN"'
Autor:
Behsen AD; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim. alenka.d.behsen@ntnu.no., Vandsemb EN; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim., Slørdahl TS; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Hematology, St. Olavs Hospital, Trondheim., Hjorth-Hansen H; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Hematology, St. Olavs Hospital, Trondheim., Quist-Paulsen P; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Hematology, St. Olavs Hospital, Trondheim., Misund K; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Medical Genetics, St. Olavs Hospital, Trondheim., Sponaas AM; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim., Waage A; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Biobank1, St. Olavs Hospital, Trondheim.
Publikováno v:
Haematologica [Haematologica] 2024 Apr 01; Vol. 109 (4), pp. 1301-1305. Date of Electronic Publication: 2024 Apr 01.
Autor:
Kim TK; Division of Hematology/Oncology, Department of Medicine.; Vanderbilt Center for Immunobiology, and.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center.; Vanderbilt Ingram Cancer Center, Nashville, Tennessee, USA.; Section of Medical Oncology.; Section of Hematology, Department of Medicine, and., Han X; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.; Pelotonia Institute for Immuno-Oncology, OSUCCC-James Cancer Hospital.; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA., Hu Q; Division of Hematology/Oncology, Department of Medicine., Vandsemb EN; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway., Fielder CM; Division of Hematology/Oncology, Department of Medicine., Hong J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea., Kim KW; Division of Hematology/Oncology, Department of Medicine., Mason EF; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center., Plowman RS; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center., Wang J; Department of Pathology, New York University Grossman School of Medicine, New York, New York, USA., Wang Q; Key Laboratory of Digestive System Tumors of Gansu Province, Lanzhou University Second Hospital, Lanzhou, China., Zhang JP; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Badri T; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Sanmamed MF; Division of Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain., Zheng L; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.; Pelotonia Institute for Immuno-Oncology, OSUCCC-James Cancer Hospital., Zhang T; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Alawa J; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Lee SW; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA., Zeidan AM; Section of Hematology, Department of Medicine, and., Halene S; Section of Hematology, Department of Medicine, and., Pillai MM; Section of Hematology, Department of Medicine, and., Chandhok NS; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida, USA., Lu J; Department of Genetics and., Xu ML; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA., Gore SD; Section of Hematology, Department of Medicine, and.; National Cancer Institute, Cancer Therapy Evaluation Program, Investigational Drug Branch, Bethesda, Maryland, USA., Chen L; Section of Medical Oncology.; Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2024 Feb 01; Vol. 134 (3). Date of Electronic Publication: 2024 Feb 01.
Autor:
Olsen JE; Ortopedisk avdeling, Oslo universitetssykehus, Ullevål., Vandsemb EN; Akuttmedisinsk avdeling, Oslo universitetssykehus., Treider MA; Avdeling for gastro- og barnekirurgi, Oslo universitetssykehus., Gjertsen M; Avdeling for radiologi og nukleærmedisin, Oslo universitetssykehus, Ullevål., Jacobsen D; Akuttmedisinsk avdeling,, Oslo universitetssykehus, og, Institutt for klinisk medisin,, Universitetet i Oslo.
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2024 Jan 05; Vol. 144 (1). Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).
Autor:
Håland E; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Moen IN; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway., Vandsemb EN; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Starheim KK; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway. Kristian.starheim@ntnu.no.; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway. Kristian.starheim@ntnu.no.; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway. Kristian.starheim@ntnu.no.
Publikováno v:
BMC research notes [BMC Res Notes] 2022 Nov 26; Vol. 15 (1), pp. 352. Date of Electronic Publication: 2022 Nov 26.
Autor:
Steiro I; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Vandsemb EN; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Elsaadi S; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Misund K; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Sponaas AM; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Børset M; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olav's University Hospital, Trondheim, Norway., Abdollahi P; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Laboratory Clinic, St. Olav's University Hospital, Trondheim, Norway., Slørdahl TS; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Hematology, St. Olav's University Hospital, Trondheim, Norway.
Publikováno v:
Oncotarget [Oncotarget] 2022 Oct 20; Vol. 13, pp. 1175-1186. Date of Electronic Publication: 2022 Oct 20.
Autor:
Kim TK; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, USA., Vandsemb EN; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Herbst RS; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, USA., Chen L; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, USA. lieping.chen@yale.edu.; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. lieping.chen@yale.edu.
Publikováno v:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2022 Jul; Vol. 21 (7), pp. 529-540. Date of Electronic Publication: 2022 Jun 14.
Autor:
Børset M; Department of Clinical and Molecular Medicine, Center for Myeloma Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Elsaadi S; Department of Clinical and Molecular Medicine, Center for Myeloma Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Vandsemb EN; Department of Clinical and Molecular Medicine, Center for Myeloma Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Hess ES; Department of Clinical and Molecular Medicine, Center for Myeloma Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Steiro IJ; Department of Clinical and Molecular Medicine, Center for Myeloma Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Cocera Fernandez M; Department of Clinical and Molecular Medicine, Center for Myeloma Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Sponaas AM; Department of Clinical and Molecular Medicine, Center for Myeloma Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Abdollahi P; Department of Clinical and Molecular Medicine, Center for Myeloma Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Laboratory Clinic, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
Publikováno v:
European journal of haematology [Eur J Haematol] 2022 Jul; Vol. 109 (1), pp. 31-40. Date of Electronic Publication: 2022 Mar 20.
Autor:
Abdollahi P; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU).; Laboratory Clinic., Vandsemb EN; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU)., Børset M; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU).; Department of Immunology and Transfusion Medicine, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.
Publikováno v:
Current opinion in clinical nutrition and metabolic care [Curr Opin Clin Nutr Metab Care] 2022 Jan 01; Vol. 25 (1), pp. 50-55.
Autor:
Mahammad N; Department of Biology, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway., Ashcroft FJ; Department of Biology, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway., Feuerherm AJ; Department of Biology, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway., Elsaadi S; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway., Vandsemb EN; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway., Børset M; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olav's University Hospital, 7491 Trondheim, Norway., Johansen B; Department of Biology, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway.
Publikováno v:
Molecules (Basel, Switzerland) [Molecules] 2021 Dec 09; Vol. 26 (24). Date of Electronic Publication: 2021 Dec 09.
Autor:
Vandsemb EN; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Rye MB; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Clinic of Surgery, St. Olavs University Hospital, Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olavs University Hospital, Trondheim, Norway.; Biocore - Bioinformatics Core Facility, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Steiro IJ; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Elsaadi S; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olavs University Hospital, Trondheim, Norway., Rø TB; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Children's Clinic, St. Olavs University Hospital, Trondheim, Norway., Slørdahl TS; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Clinic of Medicine, St. Olavs University Hospital, Trondheim, Norway., Sponaas AM; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Børset M; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, Norway., Abdollahi P; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olavs University Hospital, Trondheim, Norway.; Clinic of Medicine, St. Olavs University Hospital, Trondheim, Norway.
Publikováno v:
The FEBS journal [FEBS J] 2021 Dec; Vol. 288 (23), pp. 6700-6715. Date of Electronic Publication: 2021 Jun 20.